ativan
Generic: lorazepam
Labeler: hikma pharmaceuticals usa inc.Drug Facts
Product Profile
Brand Name
ativan
Generic Name
lorazepam
Labeler
hikma pharmaceuticals usa inc.
Dosage Form
INJECTION
Routes
Active Ingredients
lorazepam 4 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
0641-6003
Product ID
0641-6003_209b0091-c890-4f69-a693-d0594c2606fe
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA018140
DEA Schedule
civ
Listing Expiration
2026-12-31
Marketing Start
1980-07-25
Pharmacologic Class
Established (EPC)
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
06416003
Hyphenated Format
0641-6003
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
ativan (source: ndc)
Generic Name
lorazepam (source: ndc)
Application Number
NDA018140 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 4 mg/mL
Packaging
- 25 VIAL in 1 CARTON (0641-6003-25) / 1 mL in 1 VIAL (0641-6003-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "209b0091-c890-4f69-a693-d0594c2606fe", "openfda": {"nui": ["N0000175694", "M0002356"], "unii": ["O26FZP769L"], "rxcui": ["206819", "206820", "238100", "238101", "1665188", "1665190", "1665326", "1665327"], "spl_set_id": ["5fc0e987-61c9-40c4-b0d5-fcea07c8733e"], "pharm_class_cs": ["Benzodiazepines [CS]"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL in 1 CARTON (0641-6003-25) / 1 mL in 1 VIAL (0641-6003-01)", "package_ndc": "0641-6003-25", "marketing_start_date": "19800725"}], "brand_name": "Ativan", "product_id": "0641-6003_209b0091-c890-4f69-a693-d0594c2606fe", "dosage_form": "INJECTION", "pharm_class": ["Benzodiazepine [EPC]", "Benzodiazepines [CS]"], "product_ndc": "0641-6003", "dea_schedule": "CIV", "generic_name": "Lorazepam", "labeler_name": "Hikma Pharmaceuticals USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ativan", "active_ingredients": [{"name": "LORAZEPAM", "strength": "4 mg/mL"}], "application_number": "NDA018140", "marketing_category": "NDA", "marketing_start_date": "19800725", "listing_expiration_date": "20261231"}